These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19258723)

  • 1. Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan.
    Kaneshiro Y; Ichihara A; Sakoda M; Kurauchi-Mito A; Kinouchi K; Itoh H
    Kidney Blood Press Res; 2009; 32(1):51-8. PubMed ID: 19258723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M
    J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
    Ichihara A; Kaneshiro Y; Sakoda M; Takemitsu T; Itoh H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):161-6. PubMed ID: 17414228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K; Dohi Y; Nakazawa A; Sugiura T; Yamashita S; Sato K; Kimura G
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
    Karalliedde J; Smith A; DeAngelis L; Mirenda V; Kandra A; Botha J; Ferber P; Viberti G
    Hypertension; 2008 Jun; 51(6):1617-23. PubMed ID: 18426991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Itoh H
    Am J Nephrol; 2006; 26(5):462-8. PubMed ID: 17063001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V; Escobar C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial combination therapy with amlodipine/valsartan compared with monotherapy in the treatment of hypertension.
    Philipp T; Glazer RD; Wernsing M; Yen J
    J Am Soc Hypertens; 2011; 5(5):417-24. PubMed ID: 21592879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.
    Boutouyrie P; Achouba A; Trunet P; Laurent S;
    Hypertension; 2010 Jun; 55(6):1314-22. PubMed ID: 20404219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VALUE trial: a commentary.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.